To study the activation levels of positive response in tumor microenvironment (TME) brought about by a combination of vaccines and pVAX-α-PD-1 therapy, the concentrations of IL-2, IL-4, and IL-10 cytokines in the serum were determined. The gene discussed is RPL17; the disease is neoplasm.